Cerebrospinal fluid proteomics identification of biomarkers for amyloid and tau PET stages

Authors

Zhibo Wang, Capital Medical University
Yuhan Chen, Hebei North University
Katherine Gong, Washington University School of Medicine in St. Louis
Bote Zhao, Capital Medical University
Yuye Ning, Capital Medical University
Meilin Chen, Capital Medical University
Yan Li, Capital Medical University
Muhammad Ali, Washington University School of Medicine in St. Louis
Jigyasha Timsina, Washington University School of Medicine in St. Louis
Menghan Liu, Washington University School of Medicine in St. Louis
Carlos Cruchaga, Washington University School of Medicine in St. Louis
Jianping Jia, Capital Medical University

Journal

Cell Reports Medicine

Publication Date

4-15-2025

Volume

6

Issue

4

First Page

102031

Document Type

Open Access Publication

DOI

10.1016/j.xcrm.2025.102031

Rights and Permissions

Wang Z, Chen Y, Gong K, Zhao B, Ning Y, Chen M, Li Y, Ali M, Timsina J, Liu M, Cruchaga C, Jia J. Cerebrospinal fluid proteomics identification of biomarkers for amyloid and tau PET stages. Cell Rep Med. 2025 Apr 15;6(4):102031. doi: 10.1016/j.xcrm.2025.102031. Copyright 2025 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Recommended Citation

Wang, Zhibo; Chen, Yuhan; Gong, Katherine; Zhao, Bote; Ning, Yuye; Chen, Meilin; Li, Yan; Ali, Muhammad; Timsina, Jigyasha; Liu, Menghan; Cruchaga, Carlos; and Jia, Jianping, "Cerebrospinal fluid proteomics identification of biomarkers for amyloid and tau PET stages." Cell Reports Medicine. 6, 4. 102031 (2025).
https://digitalcommons.wustl.edu/oa_4/5255

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.